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Background: Enteroviruses (EVs) are a common cause of respiratory tract infections and are classified into seven
species (EVA-D and rhinoviruses [RHVs] A-C) with more than 200 different serotypes. Little is known about the role
of non-RHV EVs in respiratory infections in South America. The aim of this study was to describe the epidemiology
of non-RHV EVs detected in patients with influenza-like illness enrolled in a passive surveillance network in Peru.
Methods: Throat swabs and epidemiological data were collected from participants after obtaining verbal consent.
Viral isolation was performed in cell culture and identified by immunofluorescence assay. Serotype identification of
EV isolates was performed using commercial monoclonal antibodies. Identification of non-serotypeable isolations
was carried out by reverse transcriptase-PCR, followed by sequencing.
Results: Between 2005 and 2010, 24,239 samples were analyzed, and 9,973 (41.1%) possessed at least one
respiratory virus. EVs were found in 175 samples (0.7%). Our results revealed a clear predominance of EVB species,
90.9% (159/175). No EVDs were isolated. The mean and median ages of EV-positive subjects were 9.1 and 4.0 years,
respectively, much younger than the population sampled, 17.6 and 12.0 years. Sixteen serotypes were identified,
four EVA, 11 EVB, and one EVC species. The most common serotypes were coxsackievirus B1, coxsackievirus B2,
coxsackievirus B5, and coxsackievirus B3.
Conclusion: This study provides data about the serotypes of EVs circulating in Peru and sets the need for further
studies.
Keywords: Enterovirus, Respiratory infections, PeruBackground
Acute respiratory infections (ARIs) are a significant source
of morbidity and mortality worldwide and disproportion-
ately affect children, who have an average of two to seven
ARIs each year [1]. Enteroviruses (EVs) ―family Picorna-
viridae, genus Enterovirus―are small, non-enveloped, and
possess a single-stranded positive (messenger)-sense RNA
genome of ~7.4 kb. Historically, these viruses were charac-
terized by physical features such as stability or lability to
acid pH, insensitivity to nonionic detergents, and resistance
to ether, chloroform, and alcohol. For the most part, mo-
lecular characterization and taxonomic analysis of picorna-
virus genomes have replaced physical characterization and
has led to the current classification scheme [2-4]. EVs are* Correspondence: jose.huaman@med.navy.mil
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unless otherwise stated.classified into seven species (EVA-D and rhinoviruses
[RHVs] A-C), according to their genotypic and antigenic
characteristics. Throughout the remainder of this report,
EV will refer to only EVA, EVB, EVC, and EVD species
and not the RHV species.
EVs are transmitted mainly from person to person by
fecal-oral or oral-oral routes and by contact with upper
respiratory secretions, fomites, or fluid from blisters [2,5].
Although most EV infections remain asymptomatic, they
are also responsible for a wide range of clinical syndromes,
such as aseptic meningitis, encephalitis, myocarditis, acute
flaccid paralysis, hand-foot-and-mouth disease, and her-
pangina [2,3,6,7].
EVs have been isolated during influenza-like illnesses
(ILI) surveillance studies that our team and others have
conducted [8-13]. During the 2009 pandemic of influenza
A virus (pH1N1), coxsackievirus (CV) and echovirus (E)l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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negative samples [14]. Although EV serotypes can co-
circulate, different predominant serotypes are observed
in different regions: for example, in France [15] and
Spain [16], E11 and E6; in Taiwan [17] and China [18],
CVB3 and CVA21; and in Brazil [19], E11. Epidemio-
logical surveillance provides important information to
understand the changing patterns of EV circulation
and disease association. Accurate identification of the
EV serotype may provide relevant epidemiological in-
formation such as the cause of a localized outbreak or
the dominant EV circulating each year or it may be
used to detect new serotypes or variants. Our current
understanding of the role of EVs in respiratory infec-
tions in South America is restricted to prevalence data
in some surveillance studies of ILI or ARI [8-11,19],
with only one report of specific EV serotypes associ-
ated with ARIs [19]. The purpose of this study was to
detect, classify, and analyze the epidemiologic charac-
teristics of EVs isolated from participants with ILI in
Peru between 2005 and 2010.Results
General findings
During the 6-year study period, throat swabs were
collected from 24,239 participants aged 0-100 years
(median 12.0 years, mean 17.6 years); 53.7% of the
participants were less than 15 years. Among the 11
provinces included in this study, four accounted for
more than 71.0% of the samples. These were Piura
(23.4%), Loreto (21.0%), Lima (14.1%), and Tumbes
(13.4%). Moreover, 33.0% of the specimens were
collected in 2009 (year of pH1N1; Table 1).
At least one respiratory virus was detected in 9,973
(41.1%) specimens, with influenza A virus being the
most prevalent pathogen (62.3%). EVs were isolated in
175 participants (0.7% of samples taken) aged 0-89
years (median 4.0 years, mean 9.1 years). Rhesus
monkey kidney cells (LLCMK2) identified six of the 13
EVA isolates, 152 of the 159 EVB isolates, and all three
of the EVC isolates, while African green monkey kidney
cells (Vero E6) identified 12 of the 13 EVAs, 115 of the
159 EVBs, and none of the EVCs.
Children under 15 years were the group with highest
proportion of EVs detected (144/13,030; 1.1%)
compared with the proportion found in the group of
subjects ≥15 years (31/11,139; 0.3%), X2 = 53.3, p <
0.001. The male/female ratio for EV infection was 1.3,
a ratio (1.1) similar to the study population (X2 = 0.84,
p > 0.05). Also, our findings revealed that provinces
located on the coast had the highest proportion of EV
cases (121/13,369; 0.9%), followed by the samples
collected from sites located in the jungle (45/7,787; 0.6%)and the southern highlands (9/3,083; 0.3%), (X2 = 15.1, p <
0.001).Enterovirus species in Peru
Of the 175 EVs isolated, 13 (7.4%) were EVA species,
159 (90.9%) were EVB species, and the remaining three
(1.7%) were EVC species. The three EVC isolates were
all related to the poliovirus (PV) Sabin vaccine strain,
PV1. EVD species were not isolated in our study. EVA
and EVC species were restricted entirely to children
between five months and six years of age (median
1.5 years, mean 1.9 years).On the other hand, EVB
species were detected from participants 0-89 years of
age (median 5.0 years, mean 9.7 years). Table 1 shows
the distribution of EV serotypes by age group, collec-
tion province, and year. Sixteen different EV serotypes
were found: four EVA, 11 EVB, and one EVC serotype.
The four main serotypes isolated were CVB1 (48.0%),
CVB2 (17.7%), CVB5 (8.6%), and CVB3 (6.9%). EVs
such as EV71, CVA4, CVA6, E4, CVB4, CVA9, E30,
and PV1 were isolated exclusively in children less than
five years. Fifteen of the 17 serotypes identified in this
study were found in Piura, four of which were isolated
only there. Moreover, Loreto and Tumbes had six and
five serotypes, respectively.
Other respiratory viruses were co-detected with EV
in 42 (24.0%) samples, 40 samples with one virus (influ-
enza A virus [n = 16], herpes simplex virus, [n = 11],
adenovirus [n = 9], parainfluenza virus 1 [n = 2],
influenza B virus [n = 1], or respiratory syncytial virus
[n = 1]) and two samples with two viruses (influenza A
virus/herpes simplex virus [n = 1] and influenza B
virus/human metapneumovirus [n = 1]). At the time of
study enrollment, the EV cases had a median duration
of illness of two days. Besides the inclusion criteria
symptoms ― fever (96.0%), cough (83.1%), and sore
throat (68.8%) ― participants presented with other
common symptoms such as malaise (81.5%), rhinorrhea
(72.7%), and headache (57.8%). No difference was found
between EVA and EVB cases with respect to duration
of illness, median axillary temperature, and symptoms.Phylogenetic analyses of EV in Peru
Samples that were assigned the same serotype by BLAST
analysis clustered with their homologous prototype
strain, confirming serotype designation and supported
by high bootstrap values. In addition, to investigate the
genetic relationship among CVB1 strains (the predomin-
ant serotype in our study), we performed phylogenetic
analysis, including sequences from the GenBank data-
base of different geographical regions and year of isola-
tion. Our CVB1 isolates clustered together (nucleotide
identities 99.6 – 99.9%) and were phylogenetically close








































0-4 years 7,382 90 1 1 6 4 32 17 5 2 7 1 - 3 7 1 - 3
5-9 years 3,293 32 - - 1 - 13 10 2 - 4 - - - 1 - 1 -
10-14 years 2,355 22 - - - - 15 4 1 - 2 - - - - - - -
15-19 years 2,440 11 - - - - 7 - 1 - 2 - 1 - - - - -
20-29 years 3,557 7 - - - - 6 - 1 - - - - - - - - -
30-39 years 2,090 7 - - - - 5 - 2 - - - - - - - - -
40-49 years 1,364 2 - - - - 2 - - - - - - - - - - -
≥ 50 years 1,688 4 - - - - 4 - - - - - - - - - - -
missing 70 - - - - - - - - - - - - - - - - -
Collection province
Coast
Tumbes 3,256 23 - - - - 7 9 - 1 1 - - - 5 - - -
Piura 5,661 67 - 1 3 2 25 11 7 1 5 1 1 3 3 1 - 3
La Libertad 1,034 8 1 - - - 4 - 1 - 2 - - - - - 1 -
Lima 3,418 23 - - 2 - 14 3 3 - - - - - - - - -
Southern highlands
Arequipa 992 3 - - 1 - 1 1 - - - - - - - - - -
Cusco 1,412 3 - - - - 3 - - - - - - - - - - -
Puno 679 3 - - - - 3 - - - - - - - - - - -
Jungle
Loreto 5,082 32 - - 1 2 20 3 1 - 5 - - - - - - -
Ucayali 1,131 9 - - - - 4 4 - - 1 - - - - - - -
Madre de Dios 604 1 - - - - 1 - - - - - - - - - - -
Junin 970 3 - - - - 2 - - - 1 - - - - - - -
Loreto 5,082 32 - - 1 2 20 3 1 - 5 - - - - - - -
Collection year
2005 955 19 - 1 - - 11 5 - - 3 - - - - - - -
2006 2,076 28 - - 1 1 14 7 1 - - - - 1 2 - - -
2007 3,503 8 - - - - 3 - 1 - - 1 - - 3 - - -
2008 3,699 23 1 - 2 1 2 6 4 - 6 - - - 1 - - 1
2009 7,998 77 - - 4 2 42 12 3 - 5 - 1 2 2 1 1 1
2010 6,008 20 - - - - 12 1 3 2 1 - - - - - - 1
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http://www.virologyj.com/content/11/1/169to isolates circulating in Spain during 2008 [7] and less
related to Asian strains (Figure 1).
Discussion
This study represents a retrospective analysis of the





Figure 1 Phylogenetic analysis of CVB1. Phylogenetic analysis based on
shown at nodes. Phylogenetic relationship between Peru coxsackievirus B1
database. All Peru strains clustered with Spain strains isolated in 2008. Sequ
The prototypic CVB1, a strain from Japan, was included in the tree. CVB2 wa 6-year period and complements the sparse existing
data for the country [8-10,13]. Our findings indicate that
EVs were isolated more frequently in children younger
than 5 years, similar to other studies that also examined
EVs in older children or adults, including investigations
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partial (234 bp) VP1 sequences. Only bootstrap values >75% are
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ences were named: accession number, country/province, and year.
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90% of all EV isolates–is in concordance with other
studies that have shown EVB species as the main EV
associated with ARIs [15,17,19].
Three PV1 isolates were also observed in this study all
related to the Sabin vaccine strain. Although wild-type
PV infection has been eliminated from South America
and much of the world, vaccine-derived polioviruses still
may have public health implications. These viruses may
cause polio outbreaks in areas with low vaccine cover-
age, can replicate for years in persons who are immuno-
deficient, and may rarely cause paralysis in those with
no known immunodeficiency[20].
Our regional results revealed that the coastal region, in
particular Piura, had the highest EV isolation rate. Also,
this province provided most of the isolations (Table 1),
with the majority occurring from November through
March. These findings may have been influenced by
climatic conditions, which are notable for a rainy season
during the summer (December – March). Others have
noted a similar correlation with either the summer or
rainy season [2,4].
Our CVB1 isolates were closely related to one another,
suggesting that a single strain was responsible for the cases
of CVB1 that occurred throughout Peru from 2005 –
2010. Phylogenetically, our CVB1 strains possessed similar-
ity to an isolate from Australia detected in 2005 (found in
GenBank with no reference cited) and an even closer
relation to isolates circulating in Spain that were isolated in
a hand-foot-and-mouth disease study during 2008 [7].
Asian strains, in particular from South Korea and China,
seemed to be less related to our isolates.
A limitation of our study was the use of cell culture for
initial EV identification. No cell line is capable of support-
ing the growth of all EVs, and the use of different cells is
recommended for EV isolation [2,21,22]; however, there is
no consensus about which one(s) should be used. Some
investigators use at least four cell lines [21], and we
employed Madin-Darby canine kidney cells (MDCK),
LLCMK2, and Vero cells for routine isolation of respira-
tory viruses in our laboratory. However, detection and
identification of EVs only occurred in LLCMK2 and Vero
cells, most likely due to their established better sensitivity
for EVs compared with MDCK [2,21]. Although direct
comparisons between LLCMK2 and Vero cells for EV
isolation are uncommon, a few studies indicate that Vero
cells support the growth of EVA well and LLCMK2 cells
support the growth of EVB and EVC well, similar to our
study [21,23,24]. Utilization of other cell lines—such as
Buffalo green monkey kidney cells and continuous human
diploid fibroblasts—may have further increased our
sensitivity in detecting EVs [25], in particular those that
may not have grown well on the cell lines used in our
study.Initial use of PCR directly on the specimens would
have probably increased the detection of EVs, as shown
in an aforementioned study in Peru that detected EVs in
3% of respiratory samples [13]. It would have also
allowed a better comparison between the different cell
culture types. When used in the healthcare setting, PCR
may better elucidate the role and frequency of EVs in
central nervous system infections and hand-foot-and-
mouth disease.
Another limitation was the passive surveillance nature
of the study. Although this allowed us to collect a large
number of samples, we were not able to get mild (i.e., not
sick enough to go to a medical clinic) or severe (i.e.,
admitted directly to the hospital) cases. Also, we evaluated
our subjects at just one point in time which made it im-
possible to assess the duration or severity of the disease
after a subject left the clinic.
In summary, our data reveal that EVs are commonly
recovered from Peruvian children with ILI. Moreover, our
findings show the concomitant circulation of distinct EV
species in four provinces (Figure 2). We hope that these
results will stimulate further research of EV and ILI. Such
studies will provide justification for development of diag-
nostic and treatment options for a virus that may account




The study protocol (NMRCD.2002.0019) was classified
as less than minimal risk and was approved by the insti-
tutional review board (IRB) of the U.S. Naval Medical
Research Center in Silver Spring, Maryland. Local gov-
ernment approval was obtained to conduct the study.
This study was part of a respiratory virus surveillance
network conducted by the Peruvian MoH in collabor-
ation with NAMRU-6. Verbal consent was obtained
from all participants using an information sheet approved
and stamped by the NMRC IRB.
Specimen and data collection
ILI was defined as axillary temperature (≥37.5°C) and
cough and/or sore throat. Subjects of any age were
allowed to participate. Samples collected from January
2005 through December 2010 were included in this
study. Throat swab specimens were obtained by trained
personnel using flocked swabs and placed immediately
into a 3 ml viral transport media tube (UTM Diagnostic
Hybrids; USA). Each specimen was stored at -70°C on
site until delivery on dry ice to NAMRU-6 for laboratory
analysis. Samples analyzed in this study were collected
in health facilities located in 11 provinces divided in
three regions: coast, southern highlands, and jungle
(Figure 2, Table 1).
Figure 2 Distribution of enterovirus species by location.
Peru (2005-2010).
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All samples were inoculated onto three cell lines obtained
from the American Type Culture Collection (ATCC®):
Madin-Darby canine kidney cells (MDCK; CCL-34TM),
African green monkey kidney cells (Vero E6; CRL-
1586TM), and Rhesus monkey kidney cells (LLCMK2;
CCL-7TM). Either after 10 days of inoculation or once
cytopathic effect was observed, the presence of respiratory
viral antigens was tested in all samples by immuno-
fluorescence using commercial monoclonal antibodies
(Diagnostic Hybrids; USA). Our immunofluorescence
assay (IFA) used a blend of monoclonal antibodies for EV
(Diagnostics Hybrids; USA) and specific monoclonal anti-
bodies for 18 serotypes (Millipore; USA); PV1-3; CVA9,
CVA16, and CVA24; CVB1-6; E4, E6, E9, E11, E30, and
EV71. All assays were performed following the manufac-
turers’ established protocols. Besides EVs, viral antigens for
adenovirus, influenza A virus, influenza B virus, parainflu-
enza viruses 1-3, respiratory syncytial virus, herpes simplex
virus, and human metapneumovirus were tested by IFA
(Diagnostics Hybrids; USA).
RNA extraction, PCR, and sequencing
EVs detected with the blend of monoclonal antibodies and
with negative results for specific group and/or serotype
testing were selected for classification by molecular
methods. RNA was extracted from cell culture supernatantusing the Viral RNA Mini Kit (QIAamp, Qiagen; USA),
according to the manufacturer’s recommendations. For EV
typing, a semi-nested PCR that amplified part of the viral
protein 1 (VP1) gene was carried out using a previously
described method [26]. For direct sequencing, gene
fragments were amplified and sequenced using the Big
Dye terminator cycle sequencing kit version 3.1 (Applied
Biosystems; USA) on an 3130XL DNA Sequencer (Applied
Biosystems; USA). Nucleotide sequences of PCR products
were analyzed by sequencing using Sequencher 4.8 soft-
ware (Applied Biosystems; USA) and BioEdit software
version 7.0.0 (Isis Pharmaceuticals Inc.; USA). PVs isolated
in this study were further analyzed at the Centers for
Disease Control and Prevention (Atlanta, Georgia) by
intratypic differentiation real-time PCR and vaccine derived
poliovirus real-time PCR.Phylogenetic analyses
To determinate the serotype, the VP1 sequences obtained
were compared pairwise with sequences reported in the
GenBank database through the BLAST search system. Ac-
cording to the results of this comparison, the EV detected
in a sample was assigned to a serotype if it shared ≥75%
nucleotide or ≥88% amino acid sequence identity [27].
Moreover, to illustrate the relationship between sequences
from our most common EV serotype, CVB1, and CVB1
isolates from other locations in the world, we performed
phylogenetic analysis on a partial 234 nucleotide segment
of the VP1 gene. Multiple sequence alignments were
performed by the Clustal program in the Mac Vector soft-
ware package (Mac Vector Inc.; USA). Genetic distances
were calculated using the Kimura 2-parameter model of
nucleotide substitution and the reliability of the phyloge-
nies was estimated by bootstrap analysis with 1,000
replicates. Phylogenetic trees were reconstructed by the
neighbor-joining algorithm, using the MEGA 5.05
software.Accession numbers
Eleven partial VP1 genome sequences of CVB1 obtained
in this study have been deposited in the GenBank database
under accession numbers: KF962544 – KF962554.Statistical analyses
All the data from forms and laboratory results were
entered using Microsoft Office Access 2003. Proportions
were compared using Pearson Chi-Square test. A two-
tailed critical value of alpha = 0.05 was used for statistical
analysis using the SPSS Statistics software version 17.0
(SPSS Inc; USA). Although there was an overlap of four
months between this and a prior study from our group
[13], no sample was used in both studies.
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